Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Mercado Continuo Espanol  >  Grifols SA    GRF   ES0171996012

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercado Continuo Espanol
08/21/2015 08/24/2015 08/25/2015 08/26/2015 08/27/2015 Date
36.805(c) 35.725(c) 36.345(c) 35.81(c) 36.8(c) Last
574 193 931 201 1 106 006 879 204 753 655 Volume
-4.25% -2.93% +1.74% -1.47% +2.76% Change
More quotes
Financials (€)
Sales 2015 3 811 M
EBIT 2015 945 M
Net income 2015 547 M
Debt 2015 3 349 M
Yield 2015 1,76%
Sales 2016 4 050 M
EBIT 2016 1 043 M
Net income 2016 613 M
Debt 2016 3 053 M
Yield 2016 1,97%
PER 2015 22,53
PER 2016 20,12
EV / Sales 2015 3,80x
EV / Sales 2016 3,50x
Capitalization 11 120 M
More Financials
Company
Grifols SA is a vertically integrated global producer of plasma derivatives.Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers.The company operates through four segments: Bioessence,... 
Sector
Pharmaceuticals
Calendar
10/28Earnings Release
More about the company
Surperformance© ratings of Grifols SA
Trading Rating : Investor Rating :
More Ratings
Latest news on GRIFOLS SA
08/03 GRIFOLS : ISD completes single envelope 'clad rack' cold storage facility for Sp..
07/31 GRIFOLS : TiGenix: Dirk Buscher and Jose Terencio resign from TiGenix board of d..
07/30 GRIFOLS : rsquo; net profit rises by 16.3% to Euros 261.5 million and revenues b..
07/16 GRIFOLS : SPIN Award Program 2015
07/01 GRIFOLS : Award Winners at the 8th Annual Martín Villar Haemostasis Awards
06/27 GRIFOLS : BRIEF: New plasma donor center coming to Youngstown
06/08 GRIFOLS SA : ex-dividend day for final dividend
05/29 GRIFOLS : allocates €188 million to dividends and maintains payout at 40% of con..
More news
Sector news : Biopharmaceuticals
06:04p JOHNSON & JOHNSON : Appeals court to grills contact lens makers over minimum pri..
06:00p AMGEN : FDA Approves Amgen's New Cholesterol-Lowering Medication Repatha™ ..
05:52p AMGEN : FDA Approves Amgen's New Cholesterol-Lowering Medication Repatha(TM) (ev..
More sector news : Biopharmaceuticals
News from SeekingAlpha
11:07a TiGenix Achieves First Ever Success In Allogeneic Stem Cell Phase 3 Trial
08/21 Tracking John Paulson's Paulson & Company Portfolio - Q2 2015 Update
05/21 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
03/31 Is The Elixir Of Youth Closer Than We Think? A New Way Of Viewing Blood Produ..
03/02 TIGENIX : Locked And Loaded For Phase 3 Readout


Comments 
Advertisement
Chart GRIFOLS SA
Duration : Period :
Grifols SA Technical Analysis Chart | GRF | ES0171996012 | 4-Traders
Full-screen chart
Technical analysis trends GRIFOLS SA
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions